IMRX logo

Immuneering Corporation (IMRX)

Profile

Full Name

Immuneering Corporation

Ticker

NASDAQ: IMRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 30, 2021

Indexes

Not included

Website

https://immuneering.com

Employees

54

Key Details

Price

$5.95(+7.99%)

Market cap

$247.34M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$2.04(-8.51% YoY)

PE ratio

-

Next earnings date

Nov 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.95
    IMRX price is $5.95

    30-Day Relative Volume

    1.10
    IMRX 30-day relative volume is 1.10

    Price Performance

    Price Most recent change

    +7.99%
    IMRX price was up +7.99% on Sep 8, 2025

    Price YTD change

    +170.45%
    IMRX price is up +170.45% since January 1st

    Price 1-year change

    +404.24%
    IMRX price is up +404.24% year-on-year

    Price 3-year change

    -31.45%
    IMRX price is down -31.45% over the past 3 years

    Price Range

    Price All-time high

    $33.99
    IMRX price is currently -82.49% below its historical high of $33.99

    Price 3-year low

    $1.00
    IMRX price is currently +495.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $247.34M
    IMRX market capitalization is $247.34 million

    Market cap 3-year change

    +7.97%
    IMRX market capitalization is up +7.97% over the past 3 years

    Market cap All-time high

    $851.81M
    IMRX market capitalization is currently -70.96% below its historical high of $851.81 million

    Market cap sector rank

    53.65%
    IMRX market capitalization is higher than 53.65% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +40.19%
    IMRX shares outstanding is up +40.19% year-on-year

    Shares Outstanding 3-Year Change

    +57.51%
    IMRX shares outstanding is up +57.51% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.89
    IMRX beta is 0.89

    200-day SMA

    $2.39
    IMRX price is currently +148.84% above its 200-day simple moving average

    50-day SMA

    $4.17
    IMRX price is currently +42.84% above its 50-day simple moving average

    RSI

    65.90
    IMRX 14-day relative strength index is 65.90

    Volume

    1.10
    IMRX 30-day relative volume is 1.10

    ATR

    $0.52
    IMRX average true range is $0.52

    10-day Historical Volatility

    152.18%
    IMRX 10-day historical volatility is 152.18%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    IMRX annual revenue is $0.00

    Revenue Analysts estimate

    -
    IMRX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    IMRX annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    IMRX annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$2.04
    IMRX annual earnings per share is -$2.04

    EPS Analysts estimate

    -$1.65
    IMRX annual earnings per share is currently +23.64% higher than the consensus analysts' forecast

    EPS 1-year change

    -8.51%
    IMRX annual earnings per share is down -8.51% year-on-year

    EPS Sector rank

    36.81%
    IMRX annual earnings per share is higher than 36.81% of companies in Healthcare sector

    Profit

    Gross profit

    -$713.50K
    IMRX annual gross profit is -$713.50 thousand

    Gross margin

    -
    IMRX annual gross profit margin value is unknown

    Operating profit

    -$64.07M
    IMRX annual operating income is -$64.07 million

    Operating margin

    -
    IMRX annual operating profit margin value is unknown

    Net income

    -$61.04M
    IMRX annual net profit is -$61.04 million

    Net margin

    -
    IMRX annual net profit margin value is unknown

    Expenses

    Total expenses

    $64.07M
    IMRX annual total expenses is $64.07 million

    Operating expenses

    $64.07M
    IMRX annual total operating expenses is $64.07 million

    Cost of goods sold

    $713.50K
    IMRX annual cost of goods sold is $713.50 thousand

    Selling, general & administrative expenses

    $16.08M
    IMRX annual SGA is $16.08 million

    Depreciation and amortization

    $385.10K
    IMRX annual depreciation & amortization is $385.10 thousand

    Interest expense

    $0.00
    IMRX annual interest expense is $0.00

    Income tax

    $0.00
    IMRX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$64.07M
    IMRX annual earnings before interest & taxes is -$64.07 million

    EBITDA

    -$63.69M
    IMRX annual EBITDA is -$63.69 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $52.71M
    IMRX annual total assets is $52.71 million

    Non current assets

    $13.13M
    IMRX annual long term assets is $13.13 million

    Current assets

    $39.59M
    IMRX annual total current assets is $39.59 million

    Cash and cash equivalents

    $36.14M
    IMRX annual cash & cash equivalents is $36.14 million

    Accounts receivable

    -
    IMRX annual accounts receivable value is unknown

    Inventory

    $0.00
    IMRX annual inventory is $0.00

    Liabilities

    Total liabilities

    $11.33M
    IMRX annual total liabilities is $11.33 million

    Long term liabilities

    $3.82M
    IMRX annual total long term liabilities is $3.82 million

    Current liabilities

    $7.50M
    IMRX annual total current liabilities is $7.50 million

    Accounts payable

    $1.96M
    IMRX annual accounts payable is $1.96 million

    Debt

    Total debt

    $4.16M
    IMRX annual total debt is $4.16 million

    Total debt 1-year change

    -6.72%
    IMRX annual total debt is down -6.72% year-on-year

    Long term debt

    $3.82M
    IMRX annual long term debt is $3.82 million

    Short term debt

    $338.40K
    IMRX annual short term debt is $338.40 thousand

    Equity & Capital

    Shareholders equity

    $41.39M
    IMRX annual stockholders equity is $41.39 million

    Book value

    $41.39M
    IMRX annual book value is $41.39 million

    Retained earnings

    -$224.30M
    IMRX annual retained earnings is -$224.30 million

    Working capital

    $32.08M
    IMRX annual working capital is $32.08 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$55.00M
    IMRX annual cash flow from operations is -$55.00 million

    Cash from operations 1-year change

    -12.32%
    IMRX annual cash flow from operations is down -12.32% year-on-year

    Cash from investing

    $26.43M
    IMRX annual cash flow from investing activities is $26.43 million

    Cash from investing 1-year change

    +262.3%
    IMRX annual cash flow from investing activities is up +262.3% year-on-year

    Cash from financing

    $5.30M
    IMRX annual cash flow from financing activities is $5.30 million

    Cash from financing 1-year change

    -81.35%
    IMRX annual cash flow from financing activities is down -81.35% year-on-year

    CAPEX

    CAPEX

    $84.90K
    IMRX annual capital expenditures is $84.90 thousand

    CAPEX 1-year change

    -75.23%
    IMRX annual capital expenditures is down -75.23% year-on-year

    Free Cash Flow

    Free cash flow

    -$55.08M
    IMRX annual free cash flow is -$55.08 million

    Free cash flow 1-year change

    -11.71%
    IMRX annual free cash flow is down -11.71% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    IMRX annual gross profit margin value is unknown

    Operating margin

    -
    IMRX annual operating profit margin value is unknown

    Net margin

    -
    IMRX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -78.61%
    IMRX annual return on assets is -78.61%

    ROE

    -92.51%
    IMRX annual return on equity is -92.51%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    IMRX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    IMRX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    8.55
    IMRX price to book ratio is 8.55

    PB ratio Sector rank

    87.12%
    IMRX price to book ratio is higher than 87.12% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    IMRX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    IMRX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $224.99M
    IMRX enterprise value is $224.99 million

    Enterprise value Sector rank

    56.93%
    IMRX enterprise value is higher than 56.93% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.55
    IMRX EV/EBITDA is -3.55

    EV/EBITDA Sector rank

    27.48%
    IMRX EV/EBITDA is higher than 27.48% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.28
    IMRX annual current ratio is 5.28

    Quick ratio

    5.28
    IMRX annual quick ratio is 5.28

    Leverage

    Debt to equity

    0.10
    IMRX annual debt to equity ratio is 0.10

    Interest coverage ratio

    -
    IMRX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    IMRX piotroski f-score value is unknown

    Altman Z-Score

    3.86
    IMRX altman z-score is 3.86

    Analyst ratings

    Recent major analysts updates

    Aug 26, 25 Needham
    Buy
    Aug 14, 25 Chardan Capital
    Buy
    Jun 18, 25 Needham
    Buy
    Jun 18, 25 Mizuho
    Outperform
    Jun 18, 25 Chardan Capital
    Buy
    Jun 5, 25 Needham
    Buy
    May 7, 25 Oppenheimer
    Outperform
    May 6, 25 Chardan Capital
    Buy
    Apr 10, 25 Needham
    Buy
    Mar 24, 25 Chardan Capital
    Buy

    Institutional Ownership

    Screeners with IMRX included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Immuneering Corporation?
    • Does Immuneering Corporation pay dividends?
    • What sector is Immuneering Corporation in?
    • What industry is Immuneering Corporation in?
    • What country is Immuneering Corporation based in?
    • When did Immuneering Corporation go public?
    • Is Immuneering Corporation in the S&P 500?
    • Is Immuneering Corporation in the NASDAQ 100?
    • Is Immuneering Corporation in the Dow Jones?
    • When was Immuneering Corporation's last earnings report?
    • When does Immuneering Corporation report earnings?

    What is the ticker symbol for Immuneering Corporation?

    The ticker symbol for Immuneering Corporation is NASDAQ:IMRX

    Does Immuneering Corporation pay dividends?

    No, Immuneering Corporation does not pay dividends

    What sector is Immuneering Corporation in?

    Immuneering Corporation is in the Healthcare sector

    What industry is Immuneering Corporation in?

    Immuneering Corporation is in the Biotechnology industry

    What country is Immuneering Corporation based in?

    Immuneering Corporation is headquartered in United States

    When did Immuneering Corporation go public?

    Immuneering Corporation's initial public offering (IPO) was on July 30, 2021

    Is Immuneering Corporation in the S&P 500?

    No, Immuneering Corporation is not included in the S&P 500 index

    Is Immuneering Corporation in the NASDAQ 100?

    No, Immuneering Corporation is not included in the NASDAQ 100 index

    Is Immuneering Corporation in the Dow Jones?

    No, Immuneering Corporation is not included in the Dow Jones index

    When was Immuneering Corporation's last earnings report?

    Immuneering Corporation's most recent earnings report was on May 5, 2025

    When does Immuneering Corporation report earnings?

    The next expected earnings date for Immuneering Corporation is November 13, 2025
    On this page